class=”sc-29f61514-0 kHgAwW”>
Pharmaceutical heavyweight Novartis is one of the innovation leaders in the country. But innovation is in danger of falling under the wheels: Because employees spend too much time in the home office and too little time together in the office, “informal shopping and related positive influences such as innovation and belonging threaten to suffer.”
This is how a Novartis spokesperson told the “Basler Zeitung”. The result: Novartis backed out from the home office rule. Until recently, employees could in principle do all their work from home. The newspaper writes that since the beginning of April, office workers have to spend twelve days a month at the construction site. Converted, this means that 60 percent of the work must be done in the field.
Other companies are also recalling staff back to the office
Novartis has long been viewed as one of the most liberal companies when it comes to working from home. However, only for office staff: no one working in production at Novartis – for example at the Stein AG plant – or in the laboratory, has never benefited from the permissive home office policy. Novartis employs approximately 11,000 people in Switzerland and is one of the largest employers in that country.
Nearly three years after the start of the corona epidemic, other major employers have also returned to work-from-home rules: In the spring, for example, it was learned that Swisscom now wanted its staff to be present two days a week instead. from the previous one. (sfa)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
